Metastatic breast cancer (mBC) patients face intense financial and logistical burdens during treatment. Our findings highlight the need for flexible, patient-centered treatment approaches that reduce costs and preserve quality of life, without sacrificing provider trust and communication.

A 2025 survey of Medicare beneficiaries reveals ongoing affordability challenges that threaten treatment adherence. While recent policy reforms offer some relief, gaps remain, highlighting the need for stronger financial and patient-centered support.